Calidi Biotherapeutics Inc.
CLDI | AMEX
$1.11
$0 (-0.21%)
Sep 22, 2026, 1:05 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 45K | 450K | 450K | 450K | 405K | n/a | n/a |
Cost of Revenue | 426K | 426K | n/a | 393K | 393K | 393K | 767K | 738K | 838K | 1.2M | 1.01M | 647K | 547K | 183K | 14K | 64K | 64K | 64K | 50K | n/a | n/a |
Gross Profit | -426K | -426K | n/a | -393K | -393K | -393K | -767K | -738K | -838K | -1.2M | -1.01M | -647K | -547K | -183K | 31K | 386K | 386K | 386K | 355K | n/a | n/a |
Operating Income | -17.85M | -19.37M | -20.24M | -19.8M | -19.98M | -20.09M | -21.78M | -27.57M | -29.57M | -30.33M | -28.99M | -23.86M | -23.63M | -21.47M | -23.13M | -21.41M | -15.51M | -11.14M | -4.07M | -1.1M | -10K |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 160K | 176.5K | 176.5K | 176.5K | 16.51K | n/a | n/a | n/a |
Pretax Income | -17.49M | -19.09M | -20.05M | -20.13M | -20.03M | -20.03M | -22.19M | -26.28M | -23.23M | -29.96M | -29.2M | -28.73M | -32.07M | -24.14M | -25.42M | -21.14M | -16.61M | -12.06M | -4.32M | -833.29K | -10K |
Net Income | -17.47M | -19.03M | -19.91M | -19.95M | -19.85M | -19.9M | -22.14M | -26.28M | -23.25M | -29.98M | -29.22M | -28.74M | -32.07M | -24.15M | -25.43M | -21.16M | -16.63M | -12.06M | -4.32M | -833.29K | -10K |
Selling & General & Admin | 7.99M | 9.47M | 10.5M | 10.21M | 10.6M | 11.13M | 12.13M | 15.81M | 16.61M | 16M | 14.97M | 16.1M | 15.37M | 15.27M | 16.1M | 11.42M | 9.38M | 6.49M | 3.05M | 1.1M | 10K |
Research & Development | 9.86M | 9.9M | 9.74M | 9.19M | 8.99M | 8.56M | 8.88M | 11.02M | 12.12M | 13.13M | 13.01M | 11.31M | 10.01M | 8.31M | 7.26M | 6.24M | 4.3M | 2.81M | 1.25M | n/a | n/a |
Other Expenses | -426K | -426K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -4.2M | -2.3M | -2.3M | -200K | 4.13M | 2.23M | 2.23M | 129K | n/a | n/a |
Operating Expenses | 17.43M | 18.94M | 20.24M | 19.41M | 19.59M | 19.69M | 21.01M | 26.83M | 28.73M | 29.13M | 27.98M | 23.21M | 23.08M | 21.29M | 23.16M | 21.79M | 15.9M | 11.53M | 4.42M | 1.1M | 10K |
Interest Expense | 156K | 173K | 207K | 340K | 531K | 752K | 933K | 980K | 1.07M | 1.11M | 1.07M | 945K | 650K | 344K | 127K | 91K | 62K | 62K | 62K | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -374K | -738K | -838K | -838K | -464K | -100K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.85M | 19.37M | 20.24M | 19.8M | 19.98M | 20.09M | 21.78M | 27.57M | 29.57M | 30.33M | 28.99M | 23.86M | 23.63M | 21.47M | 23.17M | 21.86M | 15.96M | 11.59M | 4.47M | 1.1M | 10K |
Income Tax Expense | 17K | 16K | 15K | 20K | 9K | 13K | 14K | 8K | 20K | 16K | 16K | 16K | 6K | 13K | 11K | 17K | 16K | 5K | 3K | n/a | n/a |
Shares Outstanding (Basic) | 1.42M | 644.25K | 451.06K | 306.69K | 179.81K | 140.51K | 41.53K | 40.59K | 27.64K | 18.44K | 18.43K | 7.42K | 5.12K | 5.12K | 5.12K | 13.74K | 14.91K | 14.91K | 14.91K | 14.91K | 14.91K |
Shares Outstanding (Diluted) | 1.42M | 644.25K | 451.06K | 306.69K | 179.81K | 140.51K | 41.53K | 40.59K | 27.64K | 18.44K | 18.43K | 7.42K | 5.12K | 5.12K | 5.12K | 13.74K | 14.91K | 14.91K | 14.91K | 14.91K | 14.91K |
EPS (Basic) | -54.14 | -83.04 | -111.52 | -154.08 | -243.52 | -480.48 | -835.84 | -1.23K | -1.38K | -1.94K | -1.98K | -2.04K | -2.15K | -1.63K | -1.72K | -1.45K | -1.12K | -809.27 | -290.29 | -56.35 | -0.67 |
EPS (Diluted) | -54.14 | -83.04 | -111.52 | -154.08 | -243.52 | -480.48 | -835.84 | -1.23K | -1.38K | -1.94K | -1.98K | -2.04K | -2.15K | -1.63K | -1.72K | -1.45K | -1.12K | -809.27 | -290.29 | -56.35 | -0.67 |
EBITDA | -16.06M | -17.24M | -18.19M | -18.17M | -17.92M | -17.73M | -19.73M | -23.8M | -20.69M | -27.41M | -26.88M | -28.02M | -31.7M | -24.39M | -23.25M | -17.25M | -13.05M | -8.54M | -3.62M | -833.29K | -10K |
EBIT | -17.34M | -18.92M | -19.84M | -19.79M | -19.5M | -19.28M | -21.26M | -25.3M | -22.15M | -28.86M | -28.13M | -29.01M | -32.41M | -24.78M | -23.51M | -17.46M | -13.2M | -8.64M | -3.67M | -833.29K | -10K |
Depreciation & Amortization | 1.28M | 1.68M | 1.65M | 1.62M | 1.58M | 1.56M | 1.54M | 1.51M | 1.46M | 1.45M | 1.26M | 990K | 707K | 391K | 260K | 210K | 148K | 100K | 48K | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove CLDI